Bicycle Therapeutics (BCYC) Total Current Liabilities (2018 - 2026)

Bicycle Therapeutics has reported Total Current Liabilities for 9 years, with the latest figure at $48.9 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 15.16% year-over-year to $48.9 million; the trailing twelve-month figure through Mar 2026 stood at $48.9 million (down 15.16% YoY), and the FY2025 full-year result was $57.0 million, down 15.24% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $48.9 million, down from $57.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $77.4 million in Q2 2025, with the low at $35.4 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $58.2 million across 5 years, with a median of $57.0 million in 2025.
• Annual changes were most pronounced in 2022 — Total Current Liabilities surged 77.64% — and 2024, when it decreased 19.12%.
• Bicycle Therapeutics' Total Current Liabilities stood at $53.3 million in 2022, then surged by 30.36% to $69.5 million in 2023, then dropped by 3.32% to $67.2 million in 2024, then slipped by 15.24% to $57.0 million in 2025, then dropped by 14.21% to $48.9 million in 2026.
• The last three Total Current Liabilities figures came in at $48.9 million (Q1 2026), $57.0 million (Q4 2025), and $69.3 million (Q3 2025), per Business Quant data.